Evidence map›Paper›PMID 38255916›Full record

ArticleInternational journal of molecular sciences2024

Chicoric Acid Effectively Mitigated Dextran Sulfate Sodium (DSS)-Induced Colitis in BALB/c Mice by Modulating the Gut Microbiota and Fecal Metabolites.

Jiani Yang, Jie Lin, Ting Gu, Quancai Sun, Weidong Xu, Ye Peng

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Optimization of dextran sulfate sodium-induced colitis and associated mortality in BALB/c mice.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  3. International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Frontiers in pharmacology · 2025
    Article
  7. Frontiers in nutrition · 2025
    Article
  8. Therapeutic Efficacy and Underlying Mechanisms of a Mannoglucan fromInternational journal of molecular sciences · 2024
    Article
  9. Anti-Inflammatory Effects ofFoods (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Polysaccharides derived from golden mushroom (Frontiers in pharmacology · 2024
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Jiani YangSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China.
Jie LinDepartment of Nutrition and Integrative Physiology, Florida State University, Tallahassee, FL 32306, USA.
Ting GuSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China.
Quancai SunDepartment of Nutrition and Integrative Physiology, Florida State University, Tallahassee, FL 32306, USA.
Weidong XuSchool of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Ye PengFaculty of Medicine, Macau University of Science and Technology, Taipa, Macao SAR, China.
Florida State University · USJiangsu University · CNMacau University of Science and Technology · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chicoric acid (CA) has been reported to exhibit biological activities; it remains unclear, however, whether CA could regulate colitis via modulation of the gut microbiota and metabolites. This study aimed to assess CA's impact on dextran sulfate sodium (DSS)-induced colitis, the gut microbiota, and metabolites. Mice were induced with 2.5% DSS to develop colitis over a 7-day period. CA was administered intragastrically one week prior to DSS treatment and continued for 14 days. The microbial composition in the stool was determined using 16S rRNA sequencing, while non-targeted metabolomics was employed to analyze the metabolic profiles of each mouse group. The results show that CA effectively alleviated colitis, as evidenced by an increased colon length, lowered disease activity index (DAI) and histological scores, and decreased tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) expression levels. CA intervention restored the structure of gut microbiota. Specifically, it decreased the abundance of Bacteroidetes and Cyanobacteria at the phylum level and

Indexed as

Caffeic AcidsColitisGastrointestinal MicrobiomeSuccinatesAnimalsDextran SulfateHumansMiceMice, Inbred BALB CRNA, Ribosomal, 16SCaffeic Acidschicoric acidDextran SulfateRNA, Ribosomal, 16SSuccinateschicoric acidcolitisDSSgut microbiotametabolites

Identifiers

PMID38255916
PMCPMC10815209
OpenAlexW4390702770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.